Updated: Indian CDMO opens 'dedicated' R&D site for Schrödinger as part of five-year agreement
A CRO and CDMO in India has opened some labs in partnership with a drug discovery biotech and computational platform maker.
Sai Life Sciences said Thursday that it opened SSRL (Sai Schrödinger Research Laboratories) at its R&D site in Hyderabad, India. The specifics about the lab space, which Sai called a “dedicated research facility” for Schrödinger, remain unclear regarding financials and exact size.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.